Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study
- Resource Type
- Article
- Source
- In
Alzheimer's & Dementia: Translational Research & Clinical Interventions September 2017 3(3):393-401 - Subject
- Language
- ISSN
- 2352-8737